BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Navigating Europe-Specific Challenges &amp\; European Regulato
 rs Requirements\; Optimizing Preclinical Research in Neurological Models 
 &amp\; Revolutionizing Gene Therapy Delivery to CNS Targets in the Clinic
 \n\nWith systemic toxicity challenges plaguing the AAV field\, low-dose C
 NS indications are an ideal target for gene therapy. The plethora of neur
 ological indications dominating gene therapy pipelines vary from rare neu
 rological disorders to more common diseases including Parkinson’s\, epile
 psy and neurodevelopmental disorders.\n\nAs programs advance globally\, t
 he 3rd Annual Gene Therapy for Neurological Disorders Europe meeting is t
 he field’s definitive forum to showcase the European landscape’s progress
  and specific regulatory challenges. Gene therapy developers from all of 
 the world\, including Europe’s brightest minds in CNS gene therapy\, will
  unite in Paris to share their research progress and host an industry-ded
 icated discussion.\n\nGroup discounts and early booking rates are availab
 le. Please visit the website for full pricing information.\n
DTEND:20220713T183000
DTSTAMP:20260512T225914Z
DTSTART:20220711T110000
LOCATION:Pullman Paris La Défense\, 11 Avenue de l'Arche\, Courbevoie\, Îl
 e-de-France\, 92400\,
SEQUENCE:0
SUMMARY:Navigating Europe-Specific Challenges &amp\; European Regulators R
 equirements\; Optimizing Preclinical Research in Neurological Models &amp
 \; Revoluti...
UID:62caa642-37e5-4d80-8b37-6ae761de763d
END:VEVENT
END:VCALENDAR